Conference details
19th International Vascular Biology Meeting
Contact: Bernadette Englert
Mail: bernadette@navbo.org
Ph: 3017607745
The IVBM is widely recognized as a showcase for cutting edge basic and translational research in vascular biology. IVBM provides a unique forum where the international community can unite and exchange information on the most recent advancements in the field, discuss new directions and guide the next generation of scientists in vascular medicine.
The meeting will cover a broad spectrum of areas in contemporary vascular biology research, with the goal of bridging and cross-fertilizing disparate branches of the field. The broad themes include Diseases, Cells and Vascular Beds, Cellular Processes, and Emerging Topics. Specific sessions are dedicated to endocardium, heart valves, microcirculation, liver, kidney, eye, brain and lung; a wide spectrum of vascular diseases, including: atherosclerosis, peripheral vascular disease, neurovascular disease, pulmonary hypertension, vascular malformations, cancer, obesity/diabetes and thrombosis; drug discovery, imaging, tissue engineering, transcription and epigenetics, complexity and computational modeling, and new technologies. The meeting will serve as an integrative hub, featuring internationally renowned speakers with such diverse backgrounds as molecular biology, cell biology, mouse genetics, translational and clinical research, pharmacology, engineering, mathematics and physics. The conference will also feature short abstract talks, offer career development strategies for young investigators, and provide opportunities for trainees to interact with more established investigators.
Vascular biology has evolved into a major cross-disciplinary field of study with impact on many, if not most, major diseases. IVBM 2016 recognizes the importance of a comprehensive approach to the vasculature and endeavors to leverage the synergistic strengths of the international vascular biology community to advance human health.
Early registration ends August 15
Abstracts due July 26